Scalable production and immunogenicity of a cholera conjugate vaccine.
Jeon S, Kelly M, Yun J, Lee B, Park M, Whang Y, Lee C, Halvorsen YD, Verma S, Charles RC, Harris JB, Calderwood SB, Leung DT, Bhuiyan TR, Qadri F, Kamruzzaman M, Cho S, Vann WF, Xu P, Kováč P, Ganapathy R, Lynch J, Ryan ET.
Jeon S, et al. Among authors: charles rc.
Vaccine. 2021 Nov 16;39(47):6936-6946. doi: 10.1016/j.vaccine.2021.10.005. Epub 2021 Oct 27.
Vaccine. 2021.
PMID: 34716040
Free PMC article.
There is a need to develop cholera vaccines that are protective in young children under 5 years of age, which induce long-term immunity, and which can be incorporated into the Expanded Programme of Immunization (EPI) in cholera-endemic countries. ...
There is a need to develop cholera vaccines that are protective in young children under 5 years of age, which induce long-term immuni …